Antithrombosis Trials: Should we test therapeutic heparin adjusted based on activated partial thromboplastin time in septic shock?

Benzer Materyaller

• Bundled care for septic shock: An analysis of clinical trials
  Yazar:: Barochia, Amisha V., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies
  Yazar:: Altaweel, Laith, ve diğerleri
  Baskı/Yayın Bilgisi: (2009)
• Risk of death and the efficacy of eritoran tetrasodium (E5564): Design considerations for clinical trials of anti-inflammatory agents in sepsis(*)
  Yazar:: Barochia, Amisha V., ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• The Potential Contributions of Lethal and Edema Toxins to the Pathogenesis of Anthrax Associated Shock
  Yazar:: Hicks, Caitlin W., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)
• Eritoran tetrasodium (E5564) Treatment for Sepsis: Review of Preclinical and Clinical Studies
  Yazar:: Barochia, Amisha, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)